Boule Diagnostics AB | Balance Sheet

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
11,051.00
22,656.00
50,395.00
44,588.00
99,163.00
30,256
Total Accounts Receivable
57,882.00
76,105.00
56,989.00
101,203.00
110,514.00
125,839
Inventories
48,557.00
46,232.00
54,790.00
59,224.00
51,144.00
58,372
Other Current Assets
3,561.00
5,506.00
3,442.00
6,559.00
3,449.00
7,446
Total Current Assets
121,051.00
150,499.00
165,616.00
211,574.00
264,270.00
221,913
Net Property, Plant & Equipment
15,776.00
17,587.00
20,329.00
20,481.00
16,651.00
23,122
Long-Term Note Receivable
205.00
107.00
18,632.00
28,137.00
31,483.00
41,120
Intangible Assets
73,661.00
98,663.00
101,683.00
103,686.00
103,831.00
158,858
Total Assets
220,718.00
279,949.00
320,434.00
369,889.00
416,491.00
500,848
ST Debt & Current Portion LT Debt
37,944.00
41,825.00
54,876.00
30,364.00
38,678.00
Accounts Payable
14,682.00
20,998.00
22,448.00
21,936.00
24,475.00
Income Tax Payable
179.00
422.00
359.00
3,801.00
9,364.00
Other Current Liabilities
26,339.00
36,333.00
33,740.00
48,083.00
46,108.00
Total Current Liabilities
79,144.00
99,578.00
111,423.00
104,184.00
118,625.00
Long-Term Debt
8,455.00
8,951.00
7,370.00
26,926.00
26,733.00
Deferred Taxes
4,398.00
11,665.00
5,572.00
3,003.00
9,111.00
Other Liabilities
-
-
4,525.00
-
-
Total Liabilities
93,226.00
109,957.00
131,920.00
140,124.00
154,725.00
Common Equity (Total)
127,492.00
169,992.00
188,514.00
229,765.00
261,766.00
Total Shareholders' Equity
127,492.00
169,992.00
188,514.00
229,765.00
261,766.00
Total Equity
127,492.00
169,992.00
188,514.00
229,765.00
261,766.00
Liabilities & Shareholders' Equity
220,718.00
279,949.00
320,434.00
369,889.00
416,491.00

About Boule Diagnostics AB

View Profile
Address
Domnarvsgatan 4
Spanga AB 163 53
Sweden
Employees -
Website http://www.boule.se
Updated 07/08/2019
Boule Diagnostics AB engages in the development, manufacture, sale and marketing of instruments and consumable products for blood diagnostics. It offers automated blood cell counting systems for both the global human and veterinary market. The company was founded in 1992 and is headquartered in Spanga, Sweden.